Swipe to discover more

• bioMérieux Receives IVDR CE‑Marking for Two BIOFIRE^® SPOTFIRE^® Panels to Strengthen Near‑Patient Respiratory and Sore Throat Diagnostics Across Europe

  bioMérieux, a world leader in the field of in vitro diagnostics, announces that its BIOFIRE® SPOTFIRE® Respiratory/Sore Throat plus (R/STplus) Panel and BIOFIRE® SPOTFIRE® Respiratory/Sore Throat plus (R/STplus) Panel Mini have been CE-marked under the IVDR*. The certification includes conformity assessment for near-patient testing, enabling its use outside traditional laboratories, directly at the point of care.

  Read the press release
  

• Equity, Accuracy, and Stewardship: Rethinking Vaginitis Diagnosis for Women Everywhere

  Vaginitis remains a leading cause of gynecologic-related primary care visits in the United States, yet the approach to diagnosis and treatment continues to present significant challenges for clinicians and public health professionals. Recent studies underscore persistent gaps in diagnostic testing and highlight the consequences for antimicrobial stewardship and patient outcomes.

  Read the blog post
  

• Predicting Sepsis-Related Shock Earlier: How AI Could Transform Critical Care

  In the ICU, minutes count — particularly for patients with sepsis, where a sudden drop in blood pressure can signal a dangerous turn. If care teams can see that change coming, even by a couple of hours, they can prepare, personalize treatment, and potentially prevent a crisis. That’s where interpretable, clinically grounded AI can help — turning routine hospital data into early warning signs.

  Read the news